Imperative Care completes long-planned reorg into parent of 4 stroke tech companies
Acquisition
Preview
Source: FierceBiotech
Imperative Care has long been heading toward this new structure. In 2021, upon raking in a series D funding round that added $260 million to its coffers, the company said it would use the financing to help create a “strategic network” of wholly owned subsidiaries across the stroke care spectrum.
Fulfilling an imperative laid out years ago, Imperative Care has reorganized into a parent company overseeing four distinct businesses, each developing a different set of technologies to improve care for strokes and other vascular diseases.
Imperative unveiled its new structure Thursday. It now serves as the umbrella over Imperative Care Stroke, Imperative Vascular, Kandu Health and Telos Health. Together, according to the company, its businesses address not only a variety of vascular conditions but also a broad swath of the healthcare process, from initial treatment through the recovery period.
“Our vision for Imperative Care has always been to bring forward clinically meaningful innovations that are inspired and shaped by physicians and unmet clinical needs impacting patient care,” CEO Fred Khosravi said in the announcement.
“We believe that the patient is the only constant in the chain of care from detection through treatment and recovery,” he continued. “Through connected innovation, we can look holistically at what the patient needs across the full continuum of care and achieve something meaningful for patients and their families.”
Imperative Care Stroke and Telos Health are longtime units of the company. Among Imperative Care Stroke’s offerings is the Zoom Stroke Solution, an all-in-one system that doctors can use throughout the entire process of treating ischemic and hemorrhagic stroke, from accessing the clot in question, vacuuming it out and getting blood flowing normally again. Telos Health’s technology, meanwhile, focuses on robotics and other automated tools to make effective clot removal procedures more accessible.
Imperative Care Vascular, for its part, has had an on-and-off relationship with its now-parent company. It was originally born as a project within Imperative before being spun out as independent company Truvic Medical at the start of 2020, then was re-acquired by Imperative for an undisclosed amount a year later. The newly renamed business focuses on vascular diseases beyond stroke, developing devices to remove pulmonary embolisms and other blood clots throughout the body.
Kandu Health is the newest addition to the Imperative family. It launched earlier this year with a focus on creating digital health tools—mostly delivered through a smartphone app—that provide educational resources to guide stroke patients through the recovery process and their post-acute care.
Imperative has long been heading toward this new structure. In 2021, upon raking in a series D funding round that added $260 million to its coffers, the company said it would use the financing to help create a “strategic network” of wholly owned subsidiaries across the stroke care spectrum.
The company got a head-start on the reorganization at the time with the re-acquisition of Truvic Medical, which was announced alongside the funding boost.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.